Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Sunweavers: Supporting Native American Women's Vitamin D Research
Sunweavers: Supporting Native American Women's Vitamin D Research
Status: Enrolling
Updated:  3/26/2014
University of Wisconsin Osteoporosis Clinical and Research Program
mi
from
Madison, WI
Sunweavers: Supporting Native American Women's Vitamin D Research
Sunweavers: Supporting Native American Women's Vitamin D Research
Status: Enrolling
Updated: 3/26/2014
University of Wisconsin Osteoporosis Clinical and Research Program
mi
from
Madison, WI
Click here to add this to my saved trials
Evaluation of Probiotics and the Development of Clostridium Difficile Associated Diarrhea in Patients Receiving Antibiotics
Evaluation of Probiotics and the Development of Clostridium Difficile Associated Diarrhea in Patients Receiving Antibiotics
Status: Enrolling
Updated:  3/26/2014
St. Vincents East
mi
from
Birmingham, AL
Evaluation of Probiotics and the Development of Clostridium Difficile Associated Diarrhea in Patients Receiving Antibiotics
Evaluation of Probiotics and the Development of Clostridium Difficile Associated Diarrhea in Patients Receiving Antibiotics
Status: Enrolling
Updated: 3/26/2014
St. Vincents East
mi
from
Birmingham, AL
Click here to add this to my saved trials
Elemental Formula in Neonates Post Small Bowel Resection: Improved Weaning From Total Parenteral Nutrition?
The Use of Elemental Formula in Neonates Post Small Bowel Resection: Improved Success to Wean From Total Parenteral Nutrition?
Status: Enrolling
Updated:  3/28/2014
Children's Memorial Hermann Hosiptal Neonatal Intensive Care Unit
mi
from
Houston, TX
Elemental Formula in Neonates Post Small Bowel Resection: Improved Weaning From Total Parenteral Nutrition?
The Use of Elemental Formula in Neonates Post Small Bowel Resection: Improved Success to Wean From Total Parenteral Nutrition?
Status: Enrolling
Updated: 3/28/2014
Children's Memorial Hermann Hosiptal Neonatal Intensive Care Unit
mi
from
Houston, TX
Click here to add this to my saved trials
Using mHealth to Aid Opioid Medication Adherence Pilot Study
Using mHealth to Aid Opioid Medication Adherence Pilot Study
Status: Enrolling
Updated:  4/8/2014
Care Team Solutions
mi
from
Lexington, KY
Using mHealth to Aid Opioid Medication Adherence Pilot Study
Using mHealth to Aid Opioid Medication Adherence Pilot Study
Status: Enrolling
Updated: 4/8/2014
Care Team Solutions
mi
from
Lexington, KY
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Birmingham, AL
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Los Angeles, CA
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Aurora, CO
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Jacksonville, FL
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Atlanta, GA
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Chicago, IL
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Oak Lawn, IL
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
New Orleans, LA
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Boston, MA
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
St. Paul, MN
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
St. Paul, MN
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Mays Landing, NJ
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Mays Landing, NJ
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Morristown, NJ
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Morristown, NJ
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Buffalo, NY
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Buffalo, NY
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Greenville, NC
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Greenville, NC
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Nashville, TN
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Houston, TX
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Milwaukee, WI
Safety Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir
Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir and Re-assessment of Treatment Duration in Patients With Chronic Hepatitis C
Status: Enrolling
Updated:  4/10/2014
Louis Stokes Cleveland VA Medical Center
mi
from
Cleveland, OH
Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir
Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir and Re-assessment of Treatment Duration in Patients With Chronic Hepatitis C
Status: Enrolling
Updated: 4/10/2014
Louis Stokes Cleveland VA Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Occult Gastrointestinal Bleeding in Non-pulsatile Left Ventricular Assist Device(VAD)Patients
Occult Gastrointestinal Bleeding in Non-pulsatile Left Ventricular Assist Device(VAD)Patients
Status: Enrolling
Updated:  4/16/2014
Mayo Clinic
mi
from
Jacksonville, FL
Occult Gastrointestinal Bleeding in Non-pulsatile Left Ventricular Assist Device(VAD)Patients
Occult Gastrointestinal Bleeding in Non-pulsatile Left Ventricular Assist Device(VAD)Patients
Status: Enrolling
Updated: 4/16/2014
Mayo Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Occult Gastrointestinal Bleeding in Non-pulsatile Left Ventricular Assist Device(VAD)Patients
Occult Gastrointestinal Bleeding in Non-pulsatile Left Ventricular Assist Device(VAD)Patients
Status: Enrolling
Updated:  4/16/2014
The Mayo Clinic
mi
from
Rochester, MN
Occult Gastrointestinal Bleeding in Non-pulsatile Left Ventricular Assist Device(VAD)Patients
Occult Gastrointestinal Bleeding in Non-pulsatile Left Ventricular Assist Device(VAD)Patients
Status: Enrolling
Updated: 4/16/2014
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Phase 1 Study of Multiple-Dose Pharmacokinetics of Cenicriviroc in Subjects With Mild and Moderate Hepatic Impairment
An Open Label, Phase 1 Study to Evaluate the Effect of Mile and Moderate Hepatic Impairment on the Multiple-Dose Pharmacokinetics of Cenicriviroc (CVC)
Status: Enrolling
Updated:  4/18/2014
Clinical Pharmacology of Miami, Inc.
mi
from
Fort Lauderdale, FL
Phase 1 Study of Multiple-Dose Pharmacokinetics of Cenicriviroc in Subjects With Mild and Moderate Hepatic Impairment
An Open Label, Phase 1 Study to Evaluate the Effect of Mile and Moderate Hepatic Impairment on the Multiple-Dose Pharmacokinetics of Cenicriviroc (CVC)
Status: Enrolling
Updated: 4/18/2014
Clinical Pharmacology of Miami, Inc.
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Effect IV Ibuprofen and Inflammatory Responses
Randomized, Double Blind, Pilot Study on the Effect of Intravenous Ibuprofen on Inflammatory Responses in Patients Undergoing Surgery With General Anesthesia: Correlation With Clinical Outcomes
Status: Enrolling
Updated:  4/21/2014
University Hospital
mi
from
Newark, NJ
Effect IV Ibuprofen and Inflammatory Responses
Randomized, Double Blind, Pilot Study on the Effect of Intravenous Ibuprofen on Inflammatory Responses in Patients Undergoing Surgery With General Anesthesia: Correlation With Clinical Outcomes
Status: Enrolling
Updated: 4/21/2014
University Hospital
mi
from
Newark, NJ
Click here to add this to my saved trials
Effect IV Ibuprofen and Inflammatory Responses
Randomized, Double Blind, Pilot Study on the Effect of Intravenous Ibuprofen on Inflammatory Responses in Patients Undergoing Surgery With General Anesthesia: Correlation With Clinical Outcomes
Status: Enrolling
Updated:  4/21/2014
New York Methodist Hospital
mi
from
Brooklyn, NY
Effect IV Ibuprofen and Inflammatory Responses
Randomized, Double Blind, Pilot Study on the Effect of Intravenous Ibuprofen on Inflammatory Responses in Patients Undergoing Surgery With General Anesthesia: Correlation With Clinical Outcomes
Status: Enrolling
Updated: 4/21/2014
New York Methodist Hospital
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Effect IV Ibuprofen and Inflammatory Responses
Randomized, Double Blind, Pilot Study on the Effect of Intravenous Ibuprofen on Inflammatory Responses in Patients Undergoing Surgery With General Anesthesia: Correlation With Clinical Outcomes
Status: Enrolling
Updated:  4/21/2014
Mt. Sinai Medical Center
mi
from
New York, NY
Effect IV Ibuprofen and Inflammatory Responses
Randomized, Double Blind, Pilot Study on the Effect of Intravenous Ibuprofen on Inflammatory Responses in Patients Undergoing Surgery With General Anesthesia: Correlation With Clinical Outcomes
Status: Enrolling
Updated: 4/21/2014
Mt. Sinai Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Assessment of Small Bowel Healing in Crohn's Disease Patients Treated With Cimzia Using Wireless Capsule Endoscopy
Open Label Investigator Initiated, Single Site Study of Mucosal Healing in Patients With Small Bowel Crohn's Disease Treated With Certolizumab Pegol (Cimzia) Assessed by Wireless Capsule Endoscopy
Status: Enrolling
Updated:  4/23/2014
Shafran Gastroenterology Center
mi
from
Winter Park, FL
Assessment of Small Bowel Healing in Crohn's Disease Patients Treated With Cimzia Using Wireless Capsule Endoscopy
Open Label Investigator Initiated, Single Site Study of Mucosal Healing in Patients With Small Bowel Crohn's Disease Treated With Certolizumab Pegol (Cimzia) Assessed by Wireless Capsule Endoscopy
Status: Enrolling
Updated: 4/23/2014
Shafran Gastroenterology Center
mi
from
Winter Park, FL
Click here to add this to my saved trials
A Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of MK-1439 (MK-1439-019)
A 2-Part, Open-Label, Singe-Dose Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of MK-1439
Status: Enrolling
Updated:  4/23/2014
Clinical Research Facility
mi
from
Hialeah, FL
A Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of MK-1439 (MK-1439-019)
A 2-Part, Open-Label, Singe-Dose Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of MK-1439
Status: Enrolling
Updated: 4/23/2014
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
A Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of MK-1439 (MK-1439-019)
A 2-Part, Open-Label, Singe-Dose Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of MK-1439
Status: Enrolling
Updated:  4/23/2014
Clinical Research Facility
mi
from
Orlando, FL
A Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of MK-1439 (MK-1439-019)
A 2-Part, Open-Label, Singe-Dose Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of MK-1439
Status: Enrolling
Updated: 4/23/2014
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Biologic Mesh Versus Synthetic Mesh in Repair of Ventral Hernias
A Prospective Randomized Trial of Biologic Mesh Versus Synthetic Mesh for the Repair of Complex Ventral Hernias.
Status: Enrolling
Updated:  5/8/2014
Washington University
mi
from
St Louis, MO
Biologic Mesh Versus Synthetic Mesh in Repair of Ventral Hernias
A Prospective Randomized Trial of Biologic Mesh Versus Synthetic Mesh for the Repair of Complex Ventral Hernias.
Status: Enrolling
Updated: 5/8/2014
Washington University
mi
from
St Louis, MO
Click here to add this to my saved trials
Biologic Mesh Versus Synthetic Mesh in Repair of Ventral Hernias
A Prospective Randomized Trial of Biologic Mesh Versus Synthetic Mesh for the Repair of Complex Ventral Hernias.
Status: Enrolling
Updated:  5/8/2014
University Hospitals of Cleveland
mi
from
Cleveland, OH
Biologic Mesh Versus Synthetic Mesh in Repair of Ventral Hernias
A Prospective Randomized Trial of Biologic Mesh Versus Synthetic Mesh for the Repair of Complex Ventral Hernias.
Status: Enrolling
Updated: 5/8/2014
University Hospitals of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
Biologic Mesh Versus Synthetic Mesh in Repair of Ventral Hernias
A Prospective Randomized Trial of Biologic Mesh Versus Synthetic Mesh for the Repair of Complex Ventral Hernias.
Status: Enrolling
Updated:  5/8/2014
Greenville Hospital System
mi
from
Greenville, SC
Biologic Mesh Versus Synthetic Mesh in Repair of Ventral Hernias
A Prospective Randomized Trial of Biologic Mesh Versus Synthetic Mesh for the Repair of Complex Ventral Hernias.
Status: Enrolling
Updated: 5/8/2014
Greenville Hospital System
mi
from
Greenville, SC
Click here to add this to my saved trials
Biologic Mesh Versus Synthetic Mesh in Repair of Ventral Hernias
A Prospective Randomized Trial of Biologic Mesh Versus Synthetic Mesh for the Repair of Complex Ventral Hernias.
Status: Enrolling
Updated:  5/8/2014
Vanderbilt University Medical Center
mi
from
Nashville, TN
Biologic Mesh Versus Synthetic Mesh in Repair of Ventral Hernias
A Prospective Randomized Trial of Biologic Mesh Versus Synthetic Mesh for the Repair of Complex Ventral Hernias.
Status: Enrolling
Updated: 5/8/2014
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Vitamin D Supplementation for Extremely Preterm Infants
Early Vitamin D Supplementation for Prevention of Respiratory Morbidity in Extremely Preterm Infants: A Randomized Clinical Trial
Status: Enrolling
Updated:  5/13/2014
University of Alabama at Birmingham
mi
from
Birmingham, AL
Vitamin D Supplementation for Extremely Preterm Infants
Early Vitamin D Supplementation for Prevention of Respiratory Morbidity in Extremely Preterm Infants: A Randomized Clinical Trial
Status: Enrolling
Updated: 5/13/2014
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Collaborative Cognitive Behavioral Therapy / Hypnotherapy for Treatment of Pediatric Functional Gastrointestinal Disease
A Randomized Controlled Trial Comparing a Collaborative Cognitive Behavioral Therapy / Hypnotherapy Program to Standard Medical Management in the Treatment of Pediatric Functional Gastrointestinal Disease
Status: Enrolling
Updated:  5/14/2014
'Specially for Children, Dell Children's Medical Center of Central Texas
mi
from
Austin, TX
Collaborative Cognitive Behavioral Therapy / Hypnotherapy for Treatment of Pediatric Functional Gastrointestinal Disease
A Randomized Controlled Trial Comparing a Collaborative Cognitive Behavioral Therapy / Hypnotherapy Program to Standard Medical Management in the Treatment of Pediatric Functional Gastrointestinal Disease
Status: Enrolling
Updated: 5/14/2014
'Specially for Children, Dell Children's Medical Center of Central Texas
mi
from
Austin, TX
Click here to add this to my saved trials
Permission to Collect Blood Over Time for Research
Predicting DVT Risk in GI Cancer Patients Using Plasma Biomarkers
Status: Enrolling
Updated:  5/20/2014
Stanford University School of Medicine
mi
from
Stanford, CA
Permission to Collect Blood Over Time for Research
Predicting DVT Risk in GI Cancer Patients Using Plasma Biomarkers
Status: Enrolling
Updated: 5/20/2014
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers
An Interventional, Placebo-Controlled, Randomized, Double-blinded Dose Comparison, Phase I/II Study to Determine the Safety and Efficacy of a New Gel Formulation of Esmolol Hydrochloride (Galnobax®) for the Treatment of Diabetic Foot Ulcer (DFU)
Status: Enrolling
Updated:  5/27/2014
VA New England Health Care Division
mi
from
Providence, RI
Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers
An Interventional, Placebo-Controlled, Randomized, Double-blinded Dose Comparison, Phase I/II Study to Determine the Safety and Efficacy of a New Gel Formulation of Esmolol Hydrochloride (Galnobax®) for the Treatment of Diabetic Foot Ulcer (DFU)
Status: Enrolling
Updated: 5/27/2014
VA New England Health Care Division
mi
from
Providence, RI
Click here to add this to my saved trials
Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function
A Multi-center, Open Label Study to Assess Pharmacokinetics of TKI258 in Adult Cancer Patients With Normal and Impaired Hepatic Function
Status: Enrolling
Updated:  5/27/2014
Cancer Therapy & Research Center / UT Health Science Center SC
mi
from
San Antonio, TX
Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function
A Multi-center, Open Label Study to Assess Pharmacokinetics of TKI258 in Adult Cancer Patients With Normal and Impaired Hepatic Function
Status: Enrolling
Updated: 5/27/2014
Cancer Therapy & Research Center / UT Health Science Center SC
mi
from
San Antonio, TX
Click here to add this to my saved trials
Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function
A Multi-center, Open Label Study to Assess Pharmacokinetics of TKI258 in Adult Cancer Patients With Normal and Impaired Hepatic Function
Status: Enrolling
Updated:  5/27/2014
Duke University Medical Center (DUMC)
mi
from
Durham, NC
Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function
A Multi-center, Open Label Study to Assess Pharmacokinetics of TKI258 in Adult Cancer Patients With Normal and Impaired Hepatic Function
Status: Enrolling
Updated: 5/27/2014
Duke University Medical Center (DUMC)
mi
from
Durham, NC
Click here to add this to my saved trials
Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function
A Multi-center, Open Label Study to Assess Pharmacokinetics of TKI258 in Adult Cancer Patients With Normal and Impaired Hepatic Function
Status: Enrolling
Updated:  5/27/2014
University of California at Los Angeles Dept. of UCLA (4)
mi
from
Los Angeles, CA
Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function
A Multi-center, Open Label Study to Assess Pharmacokinetics of TKI258 in Adult Cancer Patients With Normal and Impaired Hepatic Function
Status: Enrolling
Updated: 5/27/2014
University of California at Los Angeles Dept. of UCLA (4)
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function
A Multi-center, Open Label Study to Assess Pharmacokinetics of TKI258 in Adult Cancer Patients With Normal and Impaired Hepatic Function
Status: Enrolling
Updated:  5/27/2014
Yale Cancer Center TKI258A2124
mi
from
New Haven, CT
Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function
A Multi-center, Open Label Study to Assess Pharmacokinetics of TKI258 in Adult Cancer Patients With Normal and Impaired Hepatic Function
Status: Enrolling
Updated: 5/27/2014
Yale Cancer Center TKI258A2124
mi
from
New Haven, CT
Click here to add this to my saved trials
Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
A Phase 3b Multi-Center, Double-Blind, Randomized, Placebo Controlled Study to Demonstrate the Safety and Efficacy of Fidaxomicin for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  5/28/2014
Clinical Research Facility
mi
from
Baltimore, MD
Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
A Phase 3b Multi-Center, Double-Blind, Randomized, Placebo Controlled Study to Demonstrate the Safety and Efficacy of Fidaxomicin for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 5/28/2014
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
A Phase 3b Multi-Center, Double-Blind, Randomized, Placebo Controlled Study to Demonstrate the Safety and Efficacy of Fidaxomicin for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  5/28/2014
Clinical Research Facility
mi
from
San Francisco, CA
Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
A Phase 3b Multi-Center, Double-Blind, Randomized, Placebo Controlled Study to Demonstrate the Safety and Efficacy of Fidaxomicin for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 5/28/2014
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
A Phase 3b Multi-Center, Double-Blind, Randomized, Placebo Controlled Study to Demonstrate the Safety and Efficacy of Fidaxomicin for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  5/28/2014
Clinical Research Facility
mi
from
Gainesville, FL
Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
A Phase 3b Multi-Center, Double-Blind, Randomized, Placebo Controlled Study to Demonstrate the Safety and Efficacy of Fidaxomicin for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 5/28/2014
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
A Phase 3b Multi-Center, Double-Blind, Randomized, Placebo Controlled Study to Demonstrate the Safety and Efficacy of Fidaxomicin for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  5/28/2014
Clinical Research Facility
mi
from
Miami, FL
Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
A Phase 3b Multi-Center, Double-Blind, Randomized, Placebo Controlled Study to Demonstrate the Safety and Efficacy of Fidaxomicin for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 5/28/2014
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
A Phase 3b Multi-Center, Double-Blind, Randomized, Placebo Controlled Study to Demonstrate the Safety and Efficacy of Fidaxomicin for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  5/28/2014
Clinical Research Facility
mi
from
Tampa, FL
Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
A Phase 3b Multi-Center, Double-Blind, Randomized, Placebo Controlled Study to Demonstrate the Safety and Efficacy of Fidaxomicin for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 5/28/2014
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
A Phase 3b Multi-Center, Double-Blind, Randomized, Placebo Controlled Study to Demonstrate the Safety and Efficacy of Fidaxomicin for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  5/28/2014
Clinical Research Facility
mi
from
Atlanta, GA
Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
A Phase 3b Multi-Center, Double-Blind, Randomized, Placebo Controlled Study to Demonstrate the Safety and Efficacy of Fidaxomicin for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 5/28/2014
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
A Phase 3b Multi-Center, Double-Blind, Randomized, Placebo Controlled Study to Demonstrate the Safety and Efficacy of Fidaxomicin for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  5/28/2014
Clinical Research Facility
mi
from
Atlanta, GA
Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
A Phase 3b Multi-Center, Double-Blind, Randomized, Placebo Controlled Study to Demonstrate the Safety and Efficacy of Fidaxomicin for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 5/28/2014
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials